Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on Sleep

NCT04832750 is registered in ClinicalTrials.gov with University of Oldenburg as lead sponsor.

NCT NCT04832750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04832750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on Sleep
Lead sponsor
University of Oldenburg
Phase
Observational
Overall status
Completed
Start date
May 3, 2021
Completion date
July 26, 2024
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder, major depressive disorder, major depressive episode